Common use
Generic Harvoni is a groundbreaking direct-acting antiviral combination medication used for the treatment of chronic hepatitis C virus (HCV) infection. Each tablet contains two powerful active ingredients: ledipasvir 90 mg (a viral NS5A inhibitor) and sofosbuvir 400 mg (a nucleotide inhibitor of the viral RNA polymerase). Together, this ledipasvir sofosbuvir combination provides a complete, interferon-free hepatitis C cure for many patients — often in as little as 8 to 12 weeks of treatment.

If you are looking to buy Harvoni online, you are choosing one of the most effective HCV treatment options available today. Sofosbuvir works by blocking the RNA polymerase enzyme that the hepatitis C virus relies on to copy its genetic material and reproduce. Ledipasvir complements this action by inhibiting the NS5A protein, which is essential for viral replication and assembly. This dual direct-acting antiviral approach interferes with HCV replication at two critical points, resulting in exceptionally high sustained virological response (SVR) rates — which is the medical term for a functional hepatitis C cure.

As a Harvoni generic, this medication is specifically approved for the treatment of chronic hepatitis C genotype 1 infection, the most common HCV genotype worldwide. The ability to treat genotype 1 hepatitis C without the need for PEG-interferon or ribavirin in many cases represents a revolutionary advancement in liver health and HCV management. This well-tolerated, once-daily pill has transformed the outlook for millions of patients living with chronic hepatitis C.

Dosage and direction
The standard adult dose for chronic hepatitis C is one tablet taken orally once daily, with or without food. Treatment duration depends on your treatment history and liver health status:

Therapy-naive patients without cirrhosis: 12 weeks (8 weeks may be considered if pretreatment HCV RNA is less than 6 million international units/mL)
Therapy-naive patients with cirrhosis: 12 weeks
Therapy-experienced patients without cirrhosis: 12 weeks
Therapy-experienced patients with cirrhosis: 24 weeks

Important considerations: Relapse rates may be influenced by baseline host and viral factors, and optimal treatment duration may differ between patient subgroups. Therapy-experienced patients are defined as those who have previously failed treatment with peginterferon alfa/ribavirin or peginterferon alfa/ribavirin plus an HCV protease inhibitor.

When you buy Harvoni for your HCV treatment, consistency is key — take the tablet at the same time every day for the full prescribed duration to maximize your chances of achieving a hepatitis C cure. Do not stop treatment early without consulting your doctor.

Precautions
Before starting this ledipasvir sofosbuvir treatment, inform your doctor about all medical conditions. Do not use Generic Harvoni if you are allergic to ledipasvir or sofosbuvir, or if you are already taking sofosbuvir tablets separately (to avoid double-dosing).

Tell your doctor if you have: liver problems other than hepatitis C (including cirrhosis or prior liver transplant); kidney disease or dialysis; HIV or AIDS; or a heart rhythm disorder for which you take amiodarone (Cordarone, Pacerone). The combination of this direct-acting antiviral with amiodarone has been associated with serious and potentially life-threatening bradycardia (slow heart rate).

If Generic Harvoni is prescribed in combination with ribavirin, additional precautions apply. Ribavirin is contraindicated in patients with: severe kidney disease; hemoglobin disorders such as sickle-cell anemia or thalassemia; or pregnancy (in either the female patient or the sexual partner of a male patient). A negative pregnancy test is typically required before and during combination therapy with ribavirin.

Avoid taking antacids within 4 hours before or after your Harvoni dose, as antacids containing aluminum or magnesium can significantly reduce drug absorption and effectiveness. Also be aware that taking this HCV treatment will not prevent you from transmitting hepatitis C to others — practice safe behaviors to protect those around you.

Generic Harvoni is not currently approved for use in patients younger than 18 years of age.

Contraindications
Alcohol consumption should be avoided during hepatitis C treatment with Generic Harvoni, as alcohol can exacerbate liver damage and potentially interfere with treatment outcomes and liver health recovery.

Women taking ribavirin in combination with Harvoni must not become pregnant during treatment and for at least 6 months afterward. Men taking ribavirin must not father a child during treatment and for 6 months after completion, as ribavirin causes severe birth defects and fetal death. Inform your healthcare provider immediately if a pregnancy occurs during this period.

The safety of ledipasvir and sofosbuvir during breastfeeding has not been established. Discuss the risks and benefits with your doctor if you are nursing.

Possible side effect
Generic Harvoni is generally very well tolerated. Common side effects may include: weakness, headache, and fatigue. These are typically mild and manageable during the course of your chronic hepatitis C treatment.

If you are also taking amiodarone, seek immediate medical attention for: extreme tiredness; unusual weakness or lack of energy; confusion or memory problems; lightheadedness or feeling faint; slowed breathing; or chest pain, slow heartbeats, or weak pulse. These symptoms may indicate serious cardiac effects requiring urgent intervention.

This is not a complete list of possible side effects. Contact your healthcare provider for medical advice about any unexpected symptoms during your HCV treatment. Serious side effects are rare but should always be reported promptly.

Drug interaction
Inform your doctor about all medications you currently use or plan to start or stop during Harvoni treatment, especially: amiodarone; ribavirin; Atripla; digoxin; other hepatitis C drugs (such as simeprevir or sofosbuvir taken separately); ritonavir used with tipranavir; rosuvastatin; St. John's wort; Stribild; tenofovir when used in combination with atazanavir, darunavir, lopinavir, or ritonavir.

Additional medications with significant interaction potential include: seizure medicines (carbamazepine, oxcarbazepine, phenobarbital, phenytoin); stomach acid reducers (cimetidine, esomeprazole, famotidine, lansoprazole, nizatidine, omeprazole, pantoprazole, ranitidine); and tuberculosis medications (rifabutin, rifampin, rifapentine).

This list is not exhaustive. Other prescription and over-the-counter medicines, vitamins, and herbal products may interact with this ledipasvir sofosbuvir combination. Provide your doctor with a complete medication inventory before you buy Harvoni online.

Missed dose
If you miss a dose of Generic Harvoni and it has been less than 18 hours since your scheduled dose time, take it as soon as possible. If more than 18 hours have passed, skip the missed dose and take the next tablet at your regular time. Do not take a double dose to compensate. If you find that you are consistently unable to take your medication as prescribed, contact your healthcare provider immediately — adherence to the full treatment course is essential for achieving a hepatitis C cure.

Overdose
If you suspect you have taken too much Generic Harvoni, seek emergency medical attention immediately or contact the Poison Help line at 1-800-222-1222. While serious overdose events are rare, prompt medical evaluation is recommended.

Storage
Store this medication at 77°F (25°C), with temporary excursions permitted between 59°F and 86°F (15°C and 30°C). Keep away from moisture and heat. Store all medications out of the reach of children and pets. Proper storage ensures the direct-acting antiviral ingredients maintain their potency throughout the treatment course.

Disclaimer
We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.